Stroke prevention: Optimizing the response to a common threat

JAMA

Volumn 292, Issue 15, 2004, Pages 1885-1887

  Toole, James F ^a   Sane, David C ^a   Bettermann, Kerstin ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; ANTITHROMBOCYTIC AGENT;

AUTONOMIC NEUROPATHY; DOSE RESPONSE; EDITORIAL; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK; ULTRASOUND; BALLOON DILATATION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; NOTE; RISK REDUCTION; STENT;

BALLOON DILATATION; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; ENDARTERECTOMY, CAROTID; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; STENTS;

EID: 5444223680     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.15.1885     Document Type: Editorial

References (16)

1. Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA. 2004;292:1867-1874.
2. Spagnoli LG, Mauriello A, Sangiorgi G, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-1852.
3. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
4. McKee SA, Sane DC, Deliargyris EN. Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thromb Haemost. 2002;88:711-715.
5. Gum PA, Kottke-Merchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003;41:961-965.
6. Alberts MJ, Bergman DL, Molner E, Jovanovic BD, Ushiwata I, Teruya J. Anti-platelet effect of aspirin in patients with cerebrovascular disease. Stroke. 2004;35:175-178.
7. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect pretreatment platelet reactivity. Circulation. 2003;107:2908-2913.
8. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109:3171-3175.
9. Fisher M, Paganini-Hill A, Martin A, et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke. In press.
10. Kagawa R, Okada Y, Shima T, Nishida M, Yamane K, Moritake K. B-mode ultrasonographic investigations of morphological changes in endarterectomized carotid artery. Surg Neurol. 2001;55:50-57.
11. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999;282:2035-2042.
12. Bo WJ, McKinney WM, Bowden RL. The origin and distribution of vasa vasorum at the bifurcation of the common carotid artery with atherosclerosis. Stroke. 1989;20:1484-1487.
13. Kastrup A, Groschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke. 2003;34:813-819.
14. Beebe HG, Archie JP, Baker WH, et al. Concern about safety of carotid angioplasty. Stroke. 1996;27:197-198.
15. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: a randomised controlled trial. Lancet. 2004;363:1491-1502.
16. Toole JF. Surgery for carotid artery stenosis: should populations be screened to detect and treat stenosis? BMJ. 2004;329:635-636.